Strong scientific consensus and surveillance data underpin the 96.2% market-implied odds against a new coronavirus pandemic in 2026. As of mid-2026, WHO classifies the global COVID-19 risk as moderate, with SARS-CoV-2 circulating at low endemic levels—test positivity below 5%, roughly 34,000 new cases reported over a recent 28-day window, and minimal hospitalizations or deaths relative to pandemic peaks. Accumulated population immunity from prior waves and vaccination, combined with the absence of variants showing both high transmissibility and severe disease potential, keeps outbreaks contained. CDC modeling indicates localized growth in some U.S. states but overall low activity. Realistic scenarios that could shift odds include emergence of a novel immune-evasive strain triggering rapid global spread or unexpected surges in vulnerable populations, though current genomic and epidemiological monitoring show no such developments.